While most MTX studies in RA revealed activated JNK pathway and subsequent induction of p53 gene expressions, there are no precisely detailed studies associated with its effect over other apoptotic markers (Spurlock et al. 2011, 2012; Wang et al. 2020a). The gene discussed is TP53; the disease is rheumatoid arthritis.